| Followers | 13 |
| Posts | 471 |
| Boards Moderated | 0 |
| Alias Born | 09/21/2017 |
Wednesday, April 01, 2020 6:40:12 AM
I don’t buy that rationale.
Don’t you think our Harvard lawyers would not have made him sign NDAs and Non Competes?
After he leaves nwbo, he joins a BP and that nwbo did not file an injunction to prevent him from being re-employed by a BP, no less by Merck?
Merck takes him back knowing full well of his possible contractual obligations?
Isn’t it “coincidental” that Duffy’s experience included helping in FDA submissions for drug approvals? We had hit a pause in our SAP submission when he “joined” 6 months ago. After that it was speculated that we had submitted the final SAP?
Isn’t it convenient that Duffy left a month ago and a PR is released that we are in for “interesting” times?
Wouldn’t it be interesting if he could have done DD / “helping” from within as an employee and after a 6month “secondment” to nwbo he gets re-employed at no loss of position by Merck?
Could it be that the “offer he could not refuse” was that he would head up the JV entity for the commercialisation of DC technology?
Join the dots guys!!
Btw, what happened to the chorus of naysayers ....he was fired by Merck?
Interesting that we ended up in the “green” when this news broke on social media?
Has Mr. Market spoken that he likes the development?
Hmmmm....interesting times ahead!!
Don’t you think our Harvard lawyers would not have made him sign NDAs and Non Competes?
After he leaves nwbo, he joins a BP and that nwbo did not file an injunction to prevent him from being re-employed by a BP, no less by Merck?
Merck takes him back knowing full well of his possible contractual obligations?
Isn’t it “coincidental” that Duffy’s experience included helping in FDA submissions for drug approvals? We had hit a pause in our SAP submission when he “joined” 6 months ago. After that it was speculated that we had submitted the final SAP?
Isn’t it convenient that Duffy left a month ago and a PR is released that we are in for “interesting” times?
Wouldn’t it be interesting if he could have done DD / “helping” from within as an employee and after a 6month “secondment” to nwbo he gets re-employed at no loss of position by Merck?
Could it be that the “offer he could not refuse” was that he would head up the JV entity for the commercialisation of DC technology?
Join the dots guys!!
Btw, what happened to the chorus of naysayers ....he was fired by Merck?
Interesting that we ended up in the “green” when this news broke on social media?
Has Mr. Market spoken that he likes the development?
Hmmmm....interesting times ahead!!
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
